Article info

Original research
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents

Authors

  1. Correspondence to Prof Silvana Morello; smorello{at}unisa.it; Dr Paolo A Ascierto; p.ascierto{at}istitutotumori.na.it
View Full Text

Citation

Turiello R, Capone M, Morretta E, et al
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents

Publication history

  • Accepted February 8, 2022
  • First published March 10, 2022.
Online issue publication 
March 10, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.